Target intelligence / Profile preview

Physical Filtration Barrier

Molecular classification
Other
01

Overview

The physical filtration barrier refers to specialized multi-layered structures, such as the glomerular filtration barrier (GFB) or the blood-brain barrier (BBB), that regulate the selective passage of substances between physiological compartments (Pollak et al., 2014, PMID: 25135271). In the kidney, the GFB consists of the fenestrated endothelium, the glomerular basement membrane, and podocytes, which collectively prevent the loss of essential proteins like albumin into the urine (Haraldsson et al., 2008, PMID: 18337451). This selective permeability is crucial for maintaining systemic homeostasis and protecting sensitive tissues from toxins or pathogens. Dysfunction of these barriers is central to the pathogenesis of diseases such as nephrotic syndrome, where barrier breakdown leads to massive proteinuria, or neuroinflammatory conditions where BBB permeability increases (Daneman & Prat, 2015, PMID: 25560979). While the barrier is a structural entity rather than a single protein, it is a major focus of therapeutic strategies aimed at preserving integrity or modulating permeability. For instance, ACE inhibitors and ARBs are used to reduce intraglomerular pressure and protect the GFB in diabetic nephropathy (Lewis et al., 1993, PMID: 8413402). Additionally, osmotic agents like mannitol are employed to temporarily disrupt the BBB for the delivery of chemotherapeutic agents to the central nervous system (StatPearls, 2023).

Other names
Glomerular filtration barrierBlood-brain barrierBiological filtration membraneSlit diaphragm complexSelective permeability barrier
02

Mechanism of action

Reduction of hydrostatic pressure, stabilization of structural proteins, or osmotic modulation of tight junctions.

03

Biological functions

FiltrationSelective permeabilityHomeostasisWaste excretionProtection
04

Disease associations

Chronic kidney diseaseNephrotic syndromeProteinuriaDiabetes mellitusNeurodegenerative disease
05

Safety considerations

Electrolyte imbalanceSystemic toxicity from barrier breachAcute kidney injuryIncreased intracranial pressure
06

Interacting drugs

Lisinopril

4 more in the full profile.

07

Biomarkers

AlbuminuriaProteinuriaGlomerular filtration rate (GFR)Creatinine clearance

Beyond the preview

Go deeper on Physical Filtration Barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physical Filtration Barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call